SEARCH

SEARCH BY CITATION

References

  • 1
    Pappas TN. Physiological satiety implications of gastro-intestinal anti-obesity surgery. Am J Clin Nutr 1992; 55: 571S2S.
  • 2
    Cullen JJ, Kelly KA. Motility disorders of the gastro-intestinal tract: Gastric motor physiology and pathophysiology. Surg Clin North Am 1993; 73: 11451160.
  • 3
    Schiavo G, Rossetto O, Benfenati F, Poulain B, Montecucco C. Tetanus and botulinum neurotoxins are zinc proteases specific for components of the neuroexocytosis apparatus. Ann N Y Acad Sci 1994; 710: 6575.
  • 4
    Pasricha PJ, Ravich WJ, Hendix RT, Sostre S, Jones B, Kalloo AN. Treatment of achalasia with intrasphincteric injection of botulinum toxin: a pilot trial. Ann Intern Med 1994; 121: 5901.
  • 5
    Gui D, Cassetta E, Anastasio G, Bentivoglio AM, Maria G, Albanese A. Botulinum toxin for chronic anal fissure. Lancet 1994; 344: 11278.
  • 6
    Maria G, Cassetta E, Gui D, Brisinda G, Bentivoglio AR, Albanese A. A comparison of botulinum toxin and saline for the treatment of chronic anal fissure. N Engl J Med 1998; 338: 21720.
  • 7
    Godevenos D, Pikoulis E, Pavlakis E, et al. The treatment of chronic anal fissure with botulinum toxin. Acta Chir Belg 2004; 104: 57780.
  • 8
    Gui D, Rossi S, Runfola M, Magalini SC. Review article: botulinum toxin in the therapy of gastrointestinal motility disorders. Aliment Pharmacol Ther 2003; 18: 116.
  • 9
    Gui D, De Gaetano A, Spada PL, Viggiano A, Cassetta E, Albanese A. Botulinum Toxin injected in gastric wall reduces body weight and food intake in rats. Aliment pharmacol Ther 2000; 14: 82934.
  • 10
    Rogers PJ. The experimental investigation of human eating behaviour. In: HindmarchI, StonierPD, eds. Human Psychopharmacology, Measures and Methods. Chichester: John Wiley and Sons Ltd, 1993: 12342.
  • 11
    Siegel JA, Wu RK, Knight LC, Zelac RE, Stern HS, Malmud LS. Radiation dose estimates for oral agents used in upper gastrointestinal disease. J Nucl Med 1983; 24: 8358.
  • 12
    Rowe B. Quantitative gastric emptying half–time clearance using dynamic and static images. J Nucl Med Technol 1991; 19: 136.
  • 13
    Siegel JA, Wu RK, Knight LC, Zelac RE, Stern HS, Malmud LS. Radiation dose estimates for oral agents used in upper gastrointestinal disease. J Nucl Med 1983; 24: 8357.
  • 14
    Chatterton BE. Nuclear Medicine in Clinical Diagnosis and Treatment, Vol. 1. Edinburgh: Churchill Livingstone, 1994: 393405.
  • 15
    Sheskin DJ. Handbook of Parametric and non Parametric Statistical Procedures, 2nd edn. Boca Raton, Fl: Chapman & Hall/CRC, 2000.
  • 16
    Tokunaga T, Nishimura R, Akagi M. Muscarinic cholinergic receptors in human gastric mucosa. Jpn J Surg 1984; 14: 1226.
  • 17
    Schemann M, Schaaf C, Mader M. Neurochemical coding of enteric neurons in the guinea pig stomach. J Comp Neurol 1995; 353: 16178.
  • 18
    Bigalke H, Habermann E. Blockade by tetanus and botulinum A toxin of postganglionic cholinergic nerve endings in the myenteric plexus. Naunyn Schmiedebergs Arch Pharmacol 1980; 312: 25563.
  • 19
    Jones OM, Brading AF, Mortensen NJ. Mechanism of action of botulinum toxin on the internal anal sphincter. Br J Surg 2004; 9: 2248.
  • 20
    James AN, Ryan JP, Parkman HP. Inhibitory effects of botulinum toxin on pyloric and antral smooth muscle. Am J Physiol Gastrointest Liver Physiol 2003; 285: G2917.
  • 21
    Rollnik JD, Meier PN, Manns MP, Göke M. Antral Injections of Botulinum A Toxin for the Treatment of Obesity. Ann Intern Med 2003; 138: 35960.
  • 22
    Caballero-Plasencia AM, Valenzuela-Barranco M, Martin-Ruiz JL, Herrerias-Gutierrez JM, Esteban-Carretero JM. Are there changes in gastric emptying during the menstrual cycle? Scand J Gastroenterol 1999; 34: 7726.
  • 23
    Gill RC, Murphy PD, Hooper HR, Bowes KL, Kingma YJ. Effect of the menstrual cycle on gastric emptying. Digestion 1987; 36: 16874.
  • 24
    Bromer MQ, Friedenberg F, Miller LS, Fisher RS, Swartz K, Parkman HP. Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis. Gastrointest Endosc 2005; 61: 8339.
  • 25
    Black JD, Dolly JO. Selective location of acceptors for botulinum neurotoxin A in the central and peripheral nervous system. Neuroscience 1987; 23: 76779.
  • 26
    Torbey CF, Singaram C, Bass P, Gaumnitz EA. Action of botulinum toxin on gut smooth muscle involves cholinergic and non-cholinergic neural pathways. Gastroenterology 1997; 112: A840.